Adamas Pharmaceuticals Inc Business Finance Contracts & Agreements

21 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC
Purchase Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2021
Binding Term Sheet by and between Adamas Pharma, LLC and Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA) Inc
Term Sheets
Adamas Pharmaceuticals Inc
Biotechnology
CA
2021
Underwriting Agreement, dated February 24, 2021, by and between the Company and SVB Leerink LLC and William Blair & Company, L.L.C., as representatives of the underwriters named...
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2021
Amendment No. 3 to the Loan Agreement dated December 1, 2020 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2021
Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC
Purchase Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2021
Binding Term Sheet by and between Adamas Pharma, LLC and Sandoz, Inc
Term Sheets
Adamas Pharmaceuticals Inc
Biotechnology
CA
2020
Amendment No. 2 to the Loan Agreement dated January 2, 2020 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2020
Description of Capital Stock
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2020
Secured Promissory Note dated November 27, 2017 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Note Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2018
Underwriting Agreement, dated January 23, 2018, by and among the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Leerink Partners LLC, and Evercore Group L.L.C.,...
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2018
Secured Promissory Note dated May 11, 2017 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Note Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2017
Loan Agreement dated May 11, 2017 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2017
ADAMAS PHARMACEUTICALS, INC. $50,000,000 COMMON STOCK SALES AGREEMENT
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2017
2,500,000 Shares ADAMAS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2016
EXHIBIT A Confidential Information and Invention Assignment Agreement
Assignment Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2014
ADAMAS PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: MARCH 23, 2014
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2014
[] Shares Adamas Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2014
ADAMAS PHARMACEUTICALS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT June 30, 2011
Investor Rights Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
ADAMAS PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: , 2014
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2014
ADAMAS PHARMACEUTICALS, INC. 2007 STOCK PLAN ADOPTED ON DECEMBER 12, 2007 AMENDED THROUGH SEPTEMBER 3, 2013
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
NEUROMOLECULAR, INC. 2002 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014